MAPT and Alzheimer disease: Collectively, these results demonstrated that miR-132 could regulate tau homeostasis, as well as protect neurons against Aβ deposition, suggesting that miR-132 supplementation could be therapeutically beneficial for treating AD (El Fatimy et al., 2018; Table 1).